openPR Logo
Press release

Pravastatin Market Trends, Business Overview, Industry Growth and Forecast to 2028

04-04-2022 11:33 AM CET | Health & Medicine

Press release from: Orion Market Research

The global pravastatin market is anticipated to grow at a significant CAGR during the forecast period (2022-2028). Pravastatin is a drug called a statin, which is used to lower LDL (bad) cholesterol and triglycerides in the blood and increase HDL (good) cholesterol. The major factor expected to drive the market is rising demand for statins as an evidence-based treatment for patients suffering from lifestyle-related diseases, such as cardiovascular disorders, diabetes, and hypercholesterolemia. Furthermore, the increasing requirement for efficient drugs to diminish LDL cholesterol is also propelling the market growth. Moreover, factors such as rising demand for over-the-counter (OTC) drugs and the growing adoption of combination therapies of statins with cholesterol diminishing compounds are fueling the growth of the market during the forecast period. Additionally, in North America, over 70% of American adults are suffering from LDL cholesterol, which increases the demand for effective treatment of LDL (bad) cholesterol which further supports the growth of the global pravastatin market.

In July 2021, a study was conducted across the US hospitals between January and September 2020 show that the Statins reduce the risk of death in a COVID-19 patient with a history of high blood pressure or heart disease. The study was done on approx. 10,500 patients across 104 the US hospitals. All of them had been admitted with a serious COVID-19 disease. After analyzing the data by American Heart Association, it was concluded that statin use was similarly linked to a 25% lower risk for developing a severe outcome as a result of COVID-19 infection. Pravastatin reduces LDL (bad) cholesterol and triglycerides in the blood and increase HDL (good) cholesterol. It is only available as a generic drug and it doesn't have a brand name version. It comes only in the form of a tablet.

Some major players in the market include Bristol-Myers Squibb, Novartis International AG, and Glenmark Pharmaceuticals Ltd., among others. The market players are contributing significantly to the growth of the market by the adoption of various strategies including mergers & acquisitions, geographical expansion, partnerships and collaborations, and new product launches, to stay competitive in the market.

(Get 15% Discount on Buying this Report)
Get Sample Copy of Pravastatin Market at: https://orionmarketreports.com/request-sample/?id=95489&submit=Request+Sample%0D%0A

Market Coverage
•The market number available for - 2021-2028
•Base year- 2021
•Forecast period- 2022-2028
•Segment Covered-
•By Dosage Type
•By End-Use
•Regions Covered-
•North America
•Europe
•Asia-Pacific
•Rest of the World

Competitive Landscape- Bristol-Myers Squibb, Novartis International AG, and Glenmark Pharmaceuticals Ltd., among others.

A full report Pravastatin Market of is available at:  https://orionmarketreports.com/pravastatin-market/95489/

Global Pravastatin Market Report by Segment
By Dosage Type
•10 mg Tablet
•20 mg Tablet
•40 mg Tablet
•80 mg Tablet
By End-Use
•Adult
•Children

Key questions addressed by the report
•What is the market growth rate?
•Which segment and region dominate the market in the base year?
•Which segment and region will project the fastest growth in the market?
•How has COVID-19 impacted the market?
•Deviation from the pre-COVID-19 forecast
•Most affected region and segment
•Who is the leader in the market?
•How players are addressing challenges to sustain growth?
•Where is the investment opportunity?

 

Media Contact:

Company Name: Orion Market Reports
Contact Person: Mr. Anurag Tiwari
Email: info@orionmarketreports.com
Contact no: +91 780-304-0404

About Us:

Orion Market Reports (OMR) endeavors to provide exclusive blend of qualitative and quantitative market research reports to clients across the globe. Our organization helps both multinational and domestic enterprises to bolster their business by providing in-depth market insights and most reliable future market trends. Our reports address all the major aspects of the markets providing insights and market outlook to global clients.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Pravastatin Market Trends, Business Overview, Industry Growth and Forecast to 2028 here

News-ID: 2594072 • Views:

More Releases from Orion Market Research

AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2033
AI-Enabled Imaging Modalities Market Rising Demand and Growth Forecast Through 2 …
AI-enabled imaging modalities market was valued at approximately USD 1.36 billion, and it is projected to reach around USD 19.78 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 34.67% from 2024 to 2033. AI-Enabled Imaging Modalities Market Overview The AI-enabled imaging modalities market is experiencing rapid growth, driven by advancements in artificial intelligence and machine learning technologies. These innovations are enhancing the capabilities of various imaging modalities, including
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Tumor Tracking Systems Market Size Analysis, Competitive Insights, Leading Playe …
Global tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing incidence of cancer and advancements in imaging and tracking technologies. These systems improve the precision of
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry Growths to 2033
Tumor Tracking Systems Market Size Future Scope, Demands and Projected Industry …
Tumor tracking systems market was valued at approximately USD 3.5 billion, and it is projected to reach around USD 6.6 billion by 2033, reflecting a compound annual growth rate (CAGR) of about 5% from 2024 to 2033. Tumor Tracking Systems Market Overview The tumor tracking systems market is experiencing steady growth, driven by the increasing prevalence of cancer and advancements in imaging technologies. These systems play a crucial role in enhancing the
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
SNP genotyping Market Size Analysis, Competitive Insights, Leading Players and G …
SNP genotyping market was valued at approximately USD 31.66 billion, and it is projected to reach around USD 238.25 billion by 2034, reflecting a compound annual growth rate (CAGR) of about 20.1% from 2024 to 2034. SNP genotyping Market Overview The SNP genotyping market is experiencing significant growth, driven by advancements in genotyping technologies, an increase in the prevalence of genetic disorders, and the expansion of pharmacogenomics and precision medicine initiatives. This

All 5 Releases


More Releases for Pravastatin

Pravastatin Sodium Tablets Market Outlook and Future Projections for 2030
The pravastatin sodium tablets market represents a dynamic and continually evolving landscape, shaped by changing consumer demands and technological advancements. In this comprehensive report, we provide an in-depth exploration of the market, designed for a wide range of stakeholders including manufacturers, suppliers, distributors, and investors. Our goal is to equip industry participants with essential insights that enable informed decision-making in an ever-changing market environment. This analysis not only examines the
[Latest] Pravastatin Market Scope: Trends, Challenges, and Growth Potential
Pravastatin Market Outlook & Investment Analysis Q1: What is the current outlook of the Pravastatin market and what factors are driving its growth? The Pravastatin market is experiencing steady growth, driven by the increasing prevalence of cardiovascular diseases and hypercholesterolemia globally. As a statin medication, Pravastatin is widely prescribed to manage high cholesterol levels and reduce the risk of stroke and heart attack, especially among aging populations. Additionally, rising health awareness, better
Pravastatin Sodium Market Key Players, Share and Forecast Outlook
"The Pravastatin Sodium Market Is Set To Grow At An Estimated CAGR Of 4.2% From 2025 To 2034, Rising From $1.2 Billion In 2024 To $1.8 Billion By 2034." On May , 2025, Exactitude Consultancy., Ltd. released a research report titled "Pravastatin Sodium Market". This report covers the global Pravastatin Sodium market sales, sales volume, price, market share, ranking of major companies, etc., and provides a detailed analysis by region, country,
Pravastatin Market Future Prediction Report By 2032
The global pravastatin market was valued at approximately $1.2 billion in 2023 and is projected to reach around $2.1 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.4% from 2024 to 2032. Pravastatin Market Overview Pravastatin, a member of the statin class of medications, is widely prescribed to lower cholesterol levels and reduce the risk of cardiovascular diseases. The market's growth is primarily driven by the increasing
The Importance of Brand Loyalty in the Pravastatin Market
Pravastatin Market size was valued at USD 1.2 Billion in 2024 and is forecasted to grow at a CAGR of 5% from 2026 to 2033, reaching USD 1.8 Billion by 2033. Pravastatin Market Future Scope The Pravastatin Market was valued at approximately USD 1.7 billion in 2022 and is expected to grow at a compound annual growth rate (CAGR) of 4.2% from 2023 to 2030. The increasing prevalence of cardiovascular diseases, driven
harma Industry Spotlight: Pravastatin Sodium API Market Dynamics and Future Fore …
Pravastatin Sodium API Market Size The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. Get Free Sample: https://reports.valuates.com/request/sample/QYRE-Auto-38X11822/Global_Pravastatin_Sodium_API_Market_Research_Report_2022 The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical